Primary systemic carnitine deficiency: Phenotypic variability, diagnostic challenges, and long‐term outcomes
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatrics International, online erschienen am 06.10.2025. Verfasst von Eymen Pınar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey. Hauptthemen laut MEDLINE: Carnitine, Hyperammonemia, Cardiomyopathies, Muscular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
Primary systemic carnitine deficiency (CDSP) is a rare inherited metabolic disorder characterized by impaired carnitine transport due to mutations in the SLC22A5 gene, leading to impaired mitochondrial fatty acid oxidation. The aim of this retrospective, descriptive study was to investigate the clinical, biochemical, and molecular features of CDSP in Turkey, where the lack of a national expanded metabolic screening program contributes to delayed diagnosis and severe complications.
Methods
The clinical, biochemical, and molecular profiles of 12 patients from eight families diagnosed between 2003 and 2025 were retrospectively analyzed. Data on family history, consanguinity, clinical manifestations—including cardiomyopathy, muscle weakness, neurological symptoms, and liver dysfunction—plasma free carnitine levels, and echocardiographic measurements were collected and analyzed.
Results
The majority of patients (92%) were from consanguineous families. Cardiomyopathy was the most common clinical feature (75%), followed by muscle weakness (50%), neurological symptoms (42%), and liver dysfunction (33%). A novel SLC22A5 variant (c.125T>C; p.Leu42Pro) was identified that expands the known genetic spectrum of CDSP. Oral carnitine supplementation significantly increased plasma free carnitine levels ( p = 0.01) and improved long‐term interventricular septal thickness Z‐scores ( p = 0.045). In addition, cholestasis was observed in two patients, suggesting an expanded disease phenotype.
Conclusion
These results emphasize the crucial role of early detection and family screening in the prevention of life‐threatening complications associated with CDSP. Long‐term carnitine therapy improves metabolic and cardiac outcomes, underscoring the need for early intervention and inclusion of CDSP in national newborn screening programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
- Division of Pediatric Nutrition and Metabolism, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
- Research Laboratory of Metabolism, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey.
- Department of Medical Documentation and Techniques, Division of Medical Laboratory Techniques, İstanbul University-Cerrahpaşa, The Vocational School of Health Services, İstanbul, Turkey.
ORCID-Profile: Eymen Pınar, Tanyel Zubarioglu, Hanım Babazade, Kağan Çalışgan, Mehmet Şerif Cansever, Ertuğrul Kıykım, Çiğdem Aktuğlu Zeybek
Zitieren
APA
Pınar, E., Zubarioglu, T., Babazade, H., Çalışgan, K., Cansever, M. Ş., Kıykım, E., & Aktuğlu Zeybek, Ç. (2025). Primary systemic carnitine deficiency: Phenotypic variability, diagnostic challenges, and long‐term outcomes. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70211
Vancouver
Pınar E, Zubarioglu T, Babazade H, Çalışgan K, Cansever MŞ, Kıykım E, et al. Primary systemic carnitine deficiency: Phenotypic variability, diagnostic challenges, and long‐term outcomes. Pediatrics International. 2025;67(1). doi:10.1111/ped.70211
BibTeX
@article{Pnar2025,
author = {Pınar, Eymen and Zubarioglu, Tanyel and Babazade, Hanım and Çalışgan, Kağan and Cansever, Mehmet Şerif and Kıykım, Ertuğrul and Aktuğlu Zeybek, Çiğdem},
title = {Primary systemic carnitine deficiency: Phenotypic variability, diagnostic challenges, and long‐term outcomes},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70211}
}
EUVIMED